4 results

• Sanctions Imposed in Valsartan Recall Lawsuits Over Drug Maker’s Discovery Violations

  July 25, 2024

  Irvin Jackson

  A Chinese generic valsartan manufacturer has been fined more than 300,000 for failing to adhere to discovery requirements and make its CEO available for depositions.

• More Than 1,200 Valsartan Lawsuits Pending in MDL Over Cancers Caused By Recalled Blood Pressure Drug

  July 15, 2024

  Irvin Jackson

  Plaintiffs and defendants have briefed the new incoming judge on the status of more than 1,200 Valsartan lawsuits ahead of a meeting later this month, which seeks to begin moving the litigation forward following the retirement of the preceding presiding judge.

• Valsartan Settlements Reached To Resolve Personal Injury, Class Action and Medical Monitoring Claims Against Hetero

  June 4, 2024

  Irvin Jackson

  A preliminary Valsartan settlement agreement has been announced that would resolve all personal injury, economic loss and medical monitoring lawsuits against Hetero, Inc., a drug manufacturer from India.

• Following Zantac Problems and Recalls, GlaxoSmithKline Sells Manufacturing Plant In India For Fraction Of Value

  April 5, 2021

  Irvin Jackson

  GlaxoSmithKline has sold a plant in India once used to make the recalled heartburn drug Zantac for only a fraction of its initial cost.